AGAP2 and non-small cell lung carcinoma: In a study of non-small-cell lung cancer, upregulation of SBF2-AS1 and AGAP2-AS1 promoted tumor-cell proliferation by negatively regulating p21, KLF2 and LATS2 [25,26].